Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-01

Clinical Trial Update: Evaluation of GeranylGeranylAcetone in Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating GeranylGeranylAcetone for heart failure with preserved ejection fraction has completed. Sponsor/locations include Amsterdam UM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GeranylGeranylAcetone

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: COMPLETED